Skip to content
Sat, 21 Nov, 2026 · Pune, IN
Pharma Solutions IndiaNews · Jobs · MSPC help · Classes
Back to news
pharma 28 Aug 1 min read· Mumbai, India

Maharashtra FDA seeks manpower for Pune Nashik drug labs

In a major boost for drug safety, Maharashtra FDA has moved to staff and equip its brand new testing labs in Pune and Nashik after civil works got done.

By Shardul Nautiyal · 28 August 2025

At a glance

OrganisationMaharashtra Food and Drug Administration
LocationMumbai, India
Categorypharma
Published28 August 2025
Pune and Nashik labs have completed civil construction but await staff and equipment to begin full testing

Key points

  • Maharashtra FDA asks state for extra manpower for new drug labs in Pune and Nashik
  • Central Sponsored Scheme provided 136 crore rupees for upgrading state drug testing infra
  • 56 vacant posts across existing Mumbai, Aurangabad and Nagpur labs to be filled soon

The Maharashtra Food and Drug Administration has formally requested the state government to sanction additional manpower for the newly constructed drug testing laboratories in Pune and Nashik. These labs were built under the Centrally Sponsored Scheme launched in 2016 17 with a total outlay of 136 crore rupees. While the buildings are ready, partitioning, equipment procurement and recruitment of trained personnel remain pending. Once fully operational, the two labs will bolster the states capacity to monitor drug quality and ensure public safety. The CSS follows a 60 40 funding model with the central government bearing the larger share.

These new labs, once staffed and equipped, will significantly enhance our ability to detect substandard and falsified medicines circulating in Maharashtra
Maharashtra FDA official

For further details contact the Maharashtra FDA headquarters in Mumbai or visit their official website for updates on recruitment notifications and lab commissioning schedules.

This is a summary prepared by the Pharma Solutions India editorial team. Verify dates, fees and eligibility with the issuing authority before acting. Editorial policy · Disclaimer.

Advertisement